0001562180-22-003323.txt : 20220407
0001562180-22-003323.hdr.sgml : 20220407
20220407163412
ACCESSION NUMBER: 0001562180-22-003323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220405
FILED AS OF DATE: 20220407
DATE AS OF CHANGE: 20220407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoffman William
CENTRAL INDEX KEY: 0001304099
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 22814310
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-04-05
false
0001531048
Inari Medical, Inc.
NARI
0001304099
Hoffman William
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
true
true
false
false
President and CEO
Common Stock
2022-04-05
4
M
false
30000.00
0.428
A
580307.00
D
Common Stock
2022-04-05
4
S
false
2771.00
88.78
D
577536.00
D
Common Stock
2022-04-05
4
S
false
7149.00
89.77
D
570387.00
D
Common Stock
2022-04-05
4
S
false
20080.00
90.63
D
550307.00
D
Stock Options (Right to buy)
0.428
2022-04-05
4
M
false
30000.00
0.428
D
2028-05-03
Common Stock
30000.00
140467.00
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
This transaction was executed in multiple trades at prices ranging from $88.20 to $89.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $89.22 to $90.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $90.22 to $91.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.
/s/ Angela Ahmad, attorney-in-fact for
2022-04-07